Printer friendly version
Thursday - Saturday September 9-11, 2004; World Conference-Program
Thursday September 9, 2004
02:00
PM Session 1: The basis of
antiinfective treatment
03:30
PM Coffee Break
Sponsors’
booths
Paul-Ehrlich-Exhibition
Ehrlich dye
laboratory
04:00
PM Session 2: Principles of
dosing and methods of individualization
N. Holford, Auckland, New
Zealand
04:40 PM PK/PD
Optimization of antiinfectives by adaptive feedback control
A. Forrest, Buffalo, USA
05:20 PM Summary
and discussion by chairmen
05:30
PM End of presentations on
Thursday
06:00
PM Opening Ceremony at the
Althoff - Frerich Hall
07:45
PM Reception at the Ehrlich
Plaza
Friday September 10, 2004
07:00
AM Registration
Sponsors’
booths
Paul-Ehrlich-Exhibition
Ehrlich dye
laboratory
08:00
AM Session 3: Antiinfectives’
drug development and regulatory processes
08:00
AM Guidelines of FDA and EMEA for
clinical studies
08:20
AM Predicting drug interactions
L.Z. Benet, San Francisco, USA
08:40
AM Adverse events and
antiinfectives’ drug interactions –
lessons of the last 20 years
R. Stahlmann,
Berlin, Germany
09:10
AM Coffee break
Sponsors’
booths
Paul-Ehrlich-Exhibition
Ehrlich dye
laboratory
09:30
AM Session 4: Antifungals and
antivirals
A. Louie, Albany, USA
09:55 AM Antivirals
G.L.
Drusano,
Albany, USA
10:20 AM Summary
and discussion by chairmen
Friday September 10, 2004
02:05
PM Session 5: Special
populations and clinical pharmacodynamics
02:05
PM Dosing issues in neonates and children
J.N. v. d. Anker, Washington, USA
02:25 PM Dosing
of antiinfectives in special populations
H. Derendorf,
Gainesville, USA
02:45
PM Dosing guidelines in patients
with renal replacement
03:05
PM Summary and discussion by
chairmen
03:20
PM Session 6: Treatment of
infection according to site of infection
03:20 PM Dosing
of antibiotics in skin and soft tissue infections
W. Graninger, Vienna, Austria
03:40 PM Dosing
of antibiotics in urinary tract infections
K.G. Naber,
Straubing, Germany
04:00
PM Dosing of antibiotics in
respiratory tract infections
04:25
PM Sepsis and other difficult
conditions
T. Welte, Hannover,
Germany
04:45
PM Summary and discussion by
chairmen
05:00
PM End of presentations on
Friday
07:00 PM Ceremonial Gala Evening to celebrate Paul Ehrlich’s 150th Birthday
(ends 11:30 PM)
Saturday September 11, 2004
07:00 AM Registration
Sponsors’
booths
Paul-Ehrlich-Exhibition
Ehrlich dye
laboratory
08:30 AM Session
7: Dosing of antiinfectives
08:30 AM Hepatitis C – dosing
regimens
S. Rossol, Rüsselsheim, Germany
08:50 AM Anti-tuberculosis
treatment
09:10 AM Preventing
antimalarial resistance
N.
White,
Bangkok, Thailand
09:30
AM Treatment and dosing of Helicobacter
pylori infection –
when pharmacology meets
clinic
P. Malfertheiner, Magdeburg, Germany
09:50 AM Summary
and discussion by chairmen
10:00
AM Coffee break
Paul-Ehrlich-Exhibition
Colors and art
– artists use Ehrlich’s colors
Ehrlich dye
laboratory
10:15
AM Session 8: Views in PK/PD
and controversies
J.J. Schentag, Buffalo, USA
10:35 AM Protein binding – a
microbiologist’s view
B. Wiedemann, Bonn, Germany
H.
Derendorf, Gainesville, Florida
11:05
AM Can resistance be prevented?
P.C. Appelbaum,
Hershey, USA
11:25 AM Can
resistance be prevented? / Intermittent vs
continuous infusion –
ISAP
position
J.W. Mouton, Nijmegen, Netherlands
11:50 AM Effectiveness
of antiinfectives: do not forget the patient!
J.C. Pechère, Geneva, Switzerland
12:05 PM Summary
and discussion by chairmen
Saturday September 11, 2004
01:30
PM “Magic Bullets” – Tools and
perspectives
01:30
PM Pharmacokinetics and
pharmacodynamics –
concepts in drug development from Ehrlich to modern PK/PD
L.Z. Benet, San Francisco, USA
02:00
PM The role of animal
experimentation in designing
antiinfective therapy from Ehrlich to today’s methods
02:30
PM The challenges of advancing
Paul Ehrlich's
chemotherapeutic principles in the present era
R.C. Moellering, Boston, USA
B. Groner, Frankfurt/M, Germany
03:30
PM End of WCDA: Closing remarks
K.G. Naber,
Straubing, Germany